01 July 2007
Constant magnetic field of 50 mT does not affect weight gain and blood glucose level in BALB/c mice
Mehrshad Abbasi, Manouchehr Nakhjavani, Sepehr Hamidi, Azam Manshadi Tarafdari, Alireza EsteghamatiMed Sci Monit 2007; 13(7): BR151-154 :: ID: 487329
Abstract
Background:
There are reports concerning a rise in blood glucose in 0.01- and 0.001-Tesla and weight loss in 0.9-Tesla constant electromagnetic fields. This study aimed to examine the effect of a 0.05-Tesla constant magnetic field on weight gain and blood glucose homeostasis in BALB/c mice.
Material/Methods:
Twenty-two young BALB/c mice were randomly divided into two equal groups. The experimental group was exposed to a 0.05-Tesla constant magnetic field created by permanent magnets for at least 10 hours a day. Apart from exposure to the magnetic field, the experimental cases and controls were kept in similar environmental conditions. The mice in both groups were weighed daily for 30 days: 10 days before, 10 days during, and 10 days after exposure to the constant magnetic field. After 30 days, the experimental group was again exposed to the magnetic field for 15 days. On the 45th day of the study, blood samples were obtained from both groups to measure blood glucose.
Results:
There was no significant difference with respect to weight gain between cases and controls, with means of 0.3±0.03 vs. 0.25±0.03 g/day, respectively. The difference between blood glucose of the cases (114.36±29.2 mg/dl) and controls (113.82±15.4 mg/dl) was also not significant.
Conclusions:
In the setting of this experiment, a 0.05-Tesla constant magnetic field had no impact on weight gain and blood glucose in BALB/c mice. It is possible that the reported effects in previous studies were partly due to sonic or thermal confounding effects caused by the electromagnets.
Keywords: Blood Glucose - metabolism, Blood - radiation effects, Body Weight, Electromagnetic Fields, Electromagnetic Phenomena, Magnetics, Time Factors, Weight Gain
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952